Correlation between elevated serum interleukin-1β, interleukin-16 levels and psychiatric symptoms in patients with schizophrenia at different stages

[1]  J Zhang,et al.  Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients , 2022, Frontiers in Psychiatry.

[2]  A. Egerton,et al.  Peripheral immune markers and antipsychotic non-response in psychosis , 2021, Schizophrenia Research.

[3]  L. Galea,et al.  Inflammation in Alzheimer's Disease: Do Sex and APOE Matter? , 2020, Journal of Alzheimer's disease : JAD.

[4]  C. M. Comim,et al.  Involvement of NLRP3 inflammasome in schizophrenia-like behaviour in young animals after maternal immune activation , 2020, Acta Neuropsychiatrica.

[5]  Y. Liu,et al.  A neuroimaging biomarker for striatal dysfunction in schizophrenia , 2020, Nature Medicine.

[6]  G. Fond,et al.  The Role of Inflammation in the Treatment of Schizophrenia , 2020, Frontiers in Psychiatry.

[7]  M. Berk,et al.  Impact of antipsychotic medication on IL‐6/STAT3 signaling axis in peripheral blood mononuclear cells of drug‐naive schizophrenia patients , 2020, Psychiatry and clinical neurosciences.

[8]  Jingping Zhao,et al.  The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia , 2019, Schizophrenia Research.

[9]  Xueqin Song,et al.  The gut microbiota promotes the pathogenesis of schizophrenia via multiple pathways. , 2019, Biochemical and biophysical research communications.

[10]  J. Bobes,et al.  Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia? , 2019, Revista de psiquiatria y salud mental.

[11]  A. Nadeem,et al.  Elevated IL-16 expression is associated with development of immune dysfunction in children with autism , 2018, Psychopharmacology.

[12]  M. Berk,et al.  Role of IL‐6/RORC/IL‐22 axis in driving Th17 pathway mediated immunopathogenesis of schizophrenia , 2018, Cytokine.

[13]  N. Bragazzi,et al.  The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia , 2018, Psychiatry Research.

[14]  D. Goldsmith,et al.  TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia , 2018, Schizophrenia Research.

[15]  Jingping Zhao,et al.  Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[16]  G. Martinotti,et al.  Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review , 2018, Current neuropharmacology.

[17]  C. Carter,et al.  Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms , 2018, Journal of Neuroinflammation.

[18]  Wenbin Guo,et al.  Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia , 2018, Front. Neurosci..

[19]  G. Carrà,et al.  Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: A meta-analysis , 2017, Neuroscience & Biobehavioral Reviews.

[20]  D. Goldsmith,et al.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression , 2016, Molecular Psychiatry.

[21]  J. Bobes,et al.  Differential blood-based biomarkers of psychopathological dimensions of schizophrenia. , 2016, Revista de psiquiatria y salud mental.

[22]  Yanmei Lu,et al.  Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies , 2016, Journal of immunology research.

[23]  Suleyman Aydin,et al.  A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA , 2015, Peptides.

[24]  L. Lv,et al.  Activation of Th17 cells in drug naïve, first episode schizophrenia , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[25]  M. Inglot,et al.  Depression and neuroticism in patients with chronic hepatitis C: correlation with peripheral blood mononuclear cells activation. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[26]  J. Soares,et al.  Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: Relationship to psychopathology , 2014, Schizophrenia Research.

[27]  N. Barnes,et al.  Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis , 2014, Schizophrenia Research.

[28]  Nancy Brahm,et al.  Schizophrenia and the immune system: pathophysiology, prevention, and treatment. , 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[29]  B. Kirkpatrick,et al.  Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects , 2011, Biological Psychiatry.

[30]  J. Margolick,et al.  Multiplex measurement of proinflammatory cytokines in human serum: comparison of the Meso Scale Discovery electrochemiluminescence assay and the Cytometric Bead Array. , 2011, Journal of immunological methods.

[31]  K. Cederbrant,et al.  Meso Scale Discovery and Luminex Comparative Analysis of Calbindin D28K , 2009, Journal of biomedicine & biotechnology.

[32]  F. Stivala,et al.  Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. , 2007, Immunology letters.

[33]  F. Nicoletti,et al.  Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia , 2006, The European journal of neuroscience.

[34]  Soo-Jung Lee,et al.  Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines. , 2006, International immunopharmacology.

[35]  S. Lee,et al.  IL‐16 expression in lymphocytes and microglia in HIV‐1 encephalitis , 2004, Neuropathology and applied neurobiology.

[36]  I. Sora,et al.  Chemokine alterations in the postmortem brains of suicide completers. , 2019, Journal of psychiatric research.

[37]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..